Scarce doses and empty vaccination centres: Germany's vaccine rollout headache

FILE PHOTO: Corina Naujoks, member of a German Red Cross mobile vaccination team injects the Pfizer-BioNTech COVID-19 vaccine at an employee of a retirement nursery in Dillenburg, Germany, January 7, 2021. REUTERS/Kai Pfaffenbach

BERLIN/DILLENBURG, Germany (Reuters) - Proud of their national reputation for efficiency, Germans are growing increasingly frustrated by the slow rollout of a COVID-19 vaccine its scientists helped develop.

Scarce vaccine supply, cumbersome paperwork, a lack of healthcare staff and an aged and immobile population are hampering efforts to get early doses of a vaccine made by U.S.-based Pfizer and German partner BioNTech into the arms of the people.